SCHEDULE II—VALUATION AND QUALIFYING ACCOUNTS

12 Months Ended

Jan. 03, 2026

SEC Schedule, 12-09, Valuation and Qualifying Accounts [Abstract]

SCHEDULE II—VALUATION AND QUALIFYING ACCOUNTS

USANA HEALTH SCIENCES, INC. AND SUBSIDIARIES

SCHEDULE II—VALUATION AND QUALIFYING ACCOUNTS

(in thousands)

Description	Balance at beginning of period		Charged to costs and expenses		Deductions		Balance at end of period
January 3, 2026
Allowance for sales returns	$	298	$	7,490	$	7,467	$	321
Allowance for credit losses	221		3		87		137
Valuation allowance - deferred tax assets	156,105		22,565		—		178,670
December 28, 2024
Allowance for sales returns	$	420	$	5,185	$	5,307	$	298
Allowance for credit losses	421		—		200		221
Valuation allowance - deferred tax assets	137,252		18,853		—		156,105
December 30, 2023
Allowance for sales returns	$	572	$	5,552	$	5,704	$	420
Allowance for credit losses	363		112		54		421
Valuation allowance - deferred tax assets	118,136		19,116		—		137,252